ALK and anaplastic large cell lymphoma: Likewise, anaplastic lymphoma kinase-1 (ALK1)-positive ALCL responds well to standard CHOP (cyclophosphamide, doxorubicin, vincristine [Oncovin], and prednisone) therapy as compared with the ALK1-negative subset.